The present invention discloses compounds of formula I ##STR00001## wherein m, n, p, R.sup.1, R.sup.2 and X, are herein defined, the compounds being novel antagonists for melanin-concentrating hormone (MCH), as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such MCH antagonists as well as methods of using them to treat obesity, metabolic disorders, eating disorders such as hyperphagia, and diabetes.

 
Web www.patentalert.com

< Methods and apparatus for creating particle derivatives of HDL with reduced lipid content

> (2S)-2-ethylphenylpropionic acid derivative

~ 00428